rdf:type |
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0010054,
umls-concept:C0024027,
umls-concept:C0033144,
umls-concept:C0039711,
umls-concept:C0232804,
umls-concept:C0441471,
umls-concept:C0547040,
umls-concept:C0680782,
umls-concept:C0687676,
umls-concept:C0936012,
umls-concept:C1280500,
umls-concept:C1517945,
umls-concept:C1706420,
umls-concept:C1708528
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-1-7
|
pubmed:abstractText |
Chronic kidney disease (CKD) is associated with an increased risk of incident cardiovascular disease (CVD); however, the role of statins for the primary prevention of acute cardiovascular events in patients with CKD and the effect of statins on kidney function loss in persons without prevalent CVD have not been studied.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-10879416,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-12529091,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-12631096,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-12761262,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-12814710,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-12859163,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-12874462,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-15037495,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-15100371,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-15364796,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-15385656,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-15625072,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-15696466,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-15998677,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-16762986,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-17986697,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-18299289,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-18528321,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-2046267,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-2313977,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-4337382,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-9264420,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932541-9613910
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1523-6838
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
42-9
|
pubmed:dateRevised |
2011-9-26
|
pubmed:meshHeading |
pubmed-meshheading:19932541-Aged,
pubmed-meshheading:19932541-Coronary Artery Disease,
pubmed-meshheading:19932541-Dose-Response Relationship, Drug,
pubmed-meshheading:19932541-Double-Blind Method,
pubmed-meshheading:19932541-Female,
pubmed-meshheading:19932541-Follow-Up Studies,
pubmed-meshheading:19932541-Glomerular Filtration Rate,
pubmed-meshheading:19932541-Humans,
pubmed-meshheading:19932541-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19932541-Incidence,
pubmed-meshheading:19932541-Kidney Failure, Chronic,
pubmed-meshheading:19932541-Kidney Function Tests,
pubmed-meshheading:19932541-Lovastatin,
pubmed-meshheading:19932541-Male,
pubmed-meshheading:19932541-Middle Aged,
pubmed-meshheading:19932541-Military Personnel,
pubmed-meshheading:19932541-Primary Prevention,
pubmed-meshheading:19932541-Texas,
pubmed-meshheading:19932541-Time Factors,
pubmed-meshheading:19932541-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study.
|
pubmed:affiliation |
Division of Renal Diseases and Hypertension, University of Colorado Denver Health Sciences Center, Aurora, CO 80220, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|